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Disruption of the perforin gene results in primary immunodeficiency and an increased susceptibility to opportunistic pathogens. Perforin-deficient
(PKO) mice fail to clear primary lymphocytic choriomeningitis virus (LCMV) Armstrong, resulting in persistent infection and functional exhaustion
of virus-specific CD8+ T cells. CD8+ T cell responses to Listeria monocytogenes (LM) challenge within the first week after LCMV infection were
diminished in both WTand PKOmice, and correlated with enhanced bacterial clearance. However, bacterial challenge at later time points generated
similar CD8 Tcell responses in both groups of mice. The phenotype and function of pre-existing LM-specific memory CD8+ Tcells were maintained
in persistently infected PKO mice. Thus persistent LCMV infection, as a result of perforin deficiency, results in dysfunction of the virus-specific
CD8+ T cell response but does not compromise the host's ability to maintain pre-existing memory CD8+ T cells or to generate new memory CD8+
T cell responses against other pathogens.
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Primary immunodeficiencies, although relatively rare, are
often associated with persistent infections of opportunistic path-
ogens, such as adenovirus, bacillus Calmette–Guerin, Candida
albicans, cytomegalovirus, Epstein–Barr virus, parainfluenza
virus 3, Pneumocystis carinii, respiratory syncitial virus, and
varicella (Stephan et al., 1993; Buckley et al., 1997). The
molecular basis of more than 120 primary immunodeficiencies
has been determined (Notarangelo et al., 2006), many of which
manifest themselves as defects in T cell development, effector
functions and immunoregulation (Cunningham-Rundles and
Ponda, 2005). Disruption of the perforin gene results in a
primary immunodeficiency associated with impaired natural
killer and cytotoxic T cell responses (Matloubian et al., 1999;⁎ Corresponding author. Department of Microbiology, University of Iowa, 3-
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doi:10.1016/j.virol.2007.08.038Stepp et al., 1999). Perforin-deficiency in humans is associated
with the disease Familial Hemophagocytic Lymphohistiocytosis
(FHL), which is uniformly fatal at an early age unless treated by
haematopoietic stem cell transplant. Mortality is associated with
dysregulated immune pathology triggered by viral infection
(Almousa et al., 2005; Katano et al., 2004). Perforin-deficient
mice are similarly more susceptible to viral infections, including
lymphocytic choriomeningitis virus (LCMV) infections (Walsh
et al., 1994; Matloubian et al., 1999).
The outcome of LCMV infections in mice depends on a
number of factors including the mouse strain, age of the mouse,
strain of the viral isolate, dose of virus, and route of infection
(Roost et al., 1988). Differences in viral and host determinants
have allowed for the development of distinct LCMV model
systems for studying viral persistence and immunosuppression
(Buchmeier et al., 1980; Oldstone, 2002). In the carrier state
model, wildtype (WT) mice are infected at birth or in utero with
LCMV and become life long carriers of the virus (Buchmeier
et al., 1980; Cihak and Lehmann-Grube, 1978). This carrier
state is associated with the clonal deletion of LCMV-specific
Fig. 1. Virus titers in LCMV-infected mice. BALB/cWTand BALB/c PKOmice
were infected intraperitoneally with 2×105 PFU of LCMVArm. (A) Mean±SD
PFU/g of spleen from 3 to 4mice/groupwere determined at the indicated days p.i.
Data was pooled from 4 individual experiments. Dashed line indicates the limit of
detection (LOD). Numbers indicatemice/groupwith viral titers above the limit of
detection. ⁎ Below limit of detection in all mice. (B) Mean±SD PFU/g of brain,
lung, and kidney from 3 mice/group in BALB/c PKO and BALB/c WT mice at
day 216 p.i.
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Oldstone, 2002). However, generalized immunosuppression
is not observed as immune responses to many heterologous
antigens remain unimpaired (Oldstone et al., 1973; Oldstone,
2002).
In a second model, intravenous or intraperitoneal infections
of adult WT mice with LCMV clone 13 (LCMVCl13) or other
highly virulent, fast growing LCMV strains, results in a vigorous
expansion of virus-specific CD8+ Tcells, however virus persists
for 90–150 days in most organs (Wherry et al., 2003). LCMV
Cl13 infection is associated with a virus-specific immunosup-
pression mediated by the progressive, epitope-dependent,
exhaustion and deletion of virus-specific CD8+ T cells (Wherry
et al., 2003). Infection of adult mice with fast growing strains of
LCMV also results in a transient generalized immunosuppres-
sion (Mims and Wainwright, 1968; Oldstone et al., 1973;
Lehmann-Grube et al., 1972; Ruedi et al., 1990; Guttler et al.,
1975) associated with the destruction and functional disruption
of antigen presenting cells (Sevilla et al., 2000; Borrow et al.,
1995; Sevilla et al., 2004).
In a third model, immunocompetent adult mice are infected
with slow growing isolates of LCMV, such the LCMV Arm
strain (LCMV Arm) (Oldstone, 2002). Like LCMVCl13,
LCMV Arm also stimulates a robust CD8+ T cell response
(Badovinac et al., 2000, 2002), which mediates viral clearance
from the spleen within 8–10 days (Wherry et al., 2003;
Matloubian et al., 1993). However, LCMVArm infection does
not result in the attrition of virus-specific CD8+ T cells (Fuller
and Zajac, 2003; Wherry et al., 2003; Khanolkar et al., 2004).
Furthermore, LCMVArm infection result in a very transient and
weak generalized immunosuppression, if any (Roost et al.,
1988), leaving APCs largely intact and unaffected (Sevilla et al.,
2000; Borrow et al., 1995).
In contrast to WT mice, perforin-deficient (PKO) mice are
unable to clear LCMV Arm (Walsh et al., 1994; Fuller and
Zajac, 2003). PKO mice on the B6 background often succumb
to LCMV Arm (Walsh et al., 1994) (data not shown) while
BALB/c PKO mice survive (Badovinac et al., 2002). Whereas
infection of WT mice by virulent strains of LCMV can be
associated with both virus-specific and generalized immuno-
suppression, it is unknown whether and how persistent LCMV
Arm infections of immunodeficient hosts affect immune
responses against heterologous pathogens. Here we use
LCMV infection of BALB/c PKO mice to examine CD8+ T
cell responses to the heterologous bacterial pathogen, Listeria
monocytogenes (LM) in a model of chronic viral infection due
to primary immunodeficiency.
Results
Virus-specific T cell responses and the duration of LCMV
infection
LCMV Arm is cleared from WT hosts between 10 and
12 days post infection (p.i.) (Wherry et al., 2003), however, high
titers of LCMV persist in BALB/c PKOmice for at least 12 days
(Badovinac et al., 2002). To determine the full course ofinfection, BALB/c WT and BALB/c PKO mice were infected
with 2×105 plaque-forming units (PFUs) of LCMV Arm and
tested for viral clearance at various time points out to 234 days
p.i. The spleens of BALB/c WT mice contained detectable virus
until day 12, then fell below the limit of detection (Fig. 1A). In
contrast, LCMVArm remained detectable in the spleens from
all BALB/c PKO mice out to 234 days p.i. (Fig. 1A). Consistent
with this, high concentrations of LCMVArm were detected in
the brain, lung, and kidneys at day 216 in BALB/c PKO, but not
BALB/c WT mice (Fig. 1B). As previously reported, BALB/c
PKO mice do not succumb to LCMVArm infection (Badovinac
et al., 2002). In addition, injection of BALB/c WT mice with
virus recovered from chronically infected BALB/c PKO mice
stimulated a robust LCMV-specific CD8 T cell response and
was cleared with normal kinetics (data not shown), indicating
that epitope escape and/or generation of variant viruses that
have gained the capacity to mediate persistent infection in WT
mice, as observed by Ahmed and Oldstone (1988) was unlikely
to account for the persistent infection or survival. Thus, LCMV
Arm establishes a long-term systemic infection in BALB/c PKO
mice.
Persistent infection of WT mice with aggressive LCMV
strains, such as LCMVCl13, is often associated with either
functional exhaustion or deletion of virus-specific CD8+ T cells
(Wherry et al., 2003); this exhaustion was reported to be
perforin-dependent in H-2b PKO mice (Matloubian et al.,
1999). To determine if chronic LCMV-infection in H-2d BALB/
c PKO mice also results in the deletion of virus-specific CD8+ T
cells, the number of NP118–126-specific CD8
+ Tcells/spleen was
312 T.D. Humphreys et al. / Virology 370 (2008) 310–322measured by MHC class I tetramer-staining. The fraction of
NP118–126-tetramer-positive CD8
+ T cells was 3- to 4-fold
lower in LCMV infected BALB/c PKO mice compared to WT
mice at day 53 (Fig. 2A). As noted previously (Badovinac et
al., 2002), early after infection the NP118–126-specific CD8
+ T
cells/spleen in BALB/c PKO mice expanded in number and
underwent contraction with similar onset and kinetics com-
pared to those of BALB/c WT mice (Fig. 2B). However, the
total number of NP118–126-specific CD8
+ T cells/spleen in
BALB/c PKO mice was reduced 2- to 5-fold compared to
BALB/c WT mice at the peak of expansion and during the
memory phase of the response (p valuesb0.05) (Fig. 2B). Thus,
persistent infection of BALB/c PKO mice is not associated with
robust clonal deletion of NP118–126-specific CD8
+ T cells. In
addition, these data support findings demonstrating perforin is
not required for the programmed contraction of virus-specific
CD8+ T cells during persistent LCMV Arm infection
(Badovinac et al., 2002).Fig. 2. BALB/c WT and BALB/c PKO mice were infected with 2×105 PFU of LCM
CD8+ Tcell responses in LCMV-infectedmice by H-2Ld-NP118 tetramer staining. Rep
percentages of H-2Ld-NP118 tetramer positive CD8+ Tcells; background stainings in u
SD of H-2Ld-NP118-specific CD8+ cells/spleen, from N3mice/group, at the indicated
assessment of virus-specific CD8+ T cell responses in LCMV-infected mice. CD8+ T c
were analyzed by peptide-stimulated ICS at various times p.i. Representative dot plot
Total number of (D) NP118–126-specific and (E) GP283–291 -specific CD8
+ T cells/spl
10 mice/time point). Data was pooled from 2 individual experiments. Dashed line inTo determine the impact of chronic infection on the function
of LCMV-specific CD8+ T cell responses in BALB/c PKO
mice, NP118–126-specific and GP283–291-specific CD8
+ T cell
responses were analyzed at various time points by peptide-
stimulated intracellular cytokine staining (ICS) for IFN-γ
(Figs. 2C–E). At day 126 p.i., the fraction of CD8+ T cells
from BALB/c PKO mice producing IFN-γ after NP118–126 and
GP283–291 peptide stimulation was reduced compared to CD8
+
T cells from WT mice (Fig. 2C). This corresponded to a 13.5-
fold reduction in the total number of NP118–126-specific, IFN-γ
producing CD8+ T cells/spleen in LCMV infected BALB/c
PKO mice compared to BALB/c WT mice (Fig. 2D) after day
126 p.i. The total number of GP283–291-specific CD8
+ T cells/
spleen in BALB/c PKO mice was also reduced at days 126 p.i
(Fig. 2E). In contrast, BALB/c PKO mice and BALB/c WT
mice had similar numbers of NP118–126- and GP283–291-specific
CD8+ T cells/spleen at day 28 p.i., prior to exhaustion. In
addition, not all infected BALB/c PKO mice made detectableVArm i.p. and analyzed at various days p.i. (A) Detection of NP118–126-specific
resentative dot plots from splenocytes harvested at day 53 p.i. Numbers represent
ninfected PKO andWTcontrol mice are in parenthesis. (B) Mean total number±
day p.i. Data was pooled from 8 individual experiments. ⁎p≤0.05. (C) Functional
ell responses to the dominant NP118–126 and the subdominant GP283–291 peptides
s from unstimulated and peptide-stimulated splenocytes harvested at day 126 p.i.
een at the indicated day p.i. Each symbol represents an individual mouse (n=3–
dicates the LOD. ⁎p≤0.05.
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+ T cell responses after
day 126 p.i. (Fig. 2E). The inability to detect GP283–291- and
NP118–126-specific CD8
+ T cells in some mice is consistent withFig. 3. Primary (L. monocytogenes)-specific CD8+ T cell responses and bacterial cleara
WTmice were infected with 2×105 PFU of LCMVArm i.p. and were subsequently inf
(Att LM) at the indicated day after LCMV infection. L. monocytogenes LLO91–99 -
(B) Representative dot plots from infectedmice. Numbers represent the percentage of CD
number) LLO91–99 peptide. Total number of LLO91–99 -specific CD8
+ Tcells/spleen in p
individual mouse (n=3–10 mice/time point). Dashed line indicates the LOD. Solid bar r
from 8 individual experiments. (E) BALB/c PKO andBALB/cWTmicewere infectedw
per spleen determined 1 day after infection. Each symbol represents an individual moufunctional exhaustion and/or deletion of virus-specific CD8+ T
cells (Wherry et al., 2003). Furthermore, the greater reduction in
the NP118–126-specific CD8
+ T cells measured by ICS (Figs.nce in LCMV-infected mice. (A) Experimental design. BALB/c PKO and BALB/c
ected with 3×106 colony forming units (CFU) of actA-deficient L. monocytogenes
specific CD8+ T cell responses were determined 7 days after Att LM infection.
8+ Tcells that produce IFN-γ after incubationwith (top number) or without (lower
anel (C) BALB/c PKOand panel (D)BALB/cWTmice. Each symbol represents an
epresents mean responses (±SEM) in LCMV-naïve control mice. Data was pooled
ith LCMVArm, 4 days later were infectedwith Att LM, and the number of bacteria
se (n=3 mice/time point). Lines indicate the mean CFU/g spleen. ⁎p≤0.05.
Fig. 4. CD8+ T cell responses to peptide-coated dendritic cells and Att LM
infection in LCMV-infected mice. (A) Experimental design. BALB/c PKO and
BALB/c WT mice were infected with 2×105 PFU of LCMVArm i.p. At days 7,
12, or 18 post LCMV infection these mice and LCMV-naïve control mice were
injected with 3×106 CFU Att LM or LLO91–99-coated dendritic cells (DC-
LLO). CD8+ T cell responses to LLO91–99 and NP118–126 were analyzed by ICS
7 days later. (B) Total number of LLO91–99 -specific CD8
+ T cells/spleen at the
indicated time point. Each symbol represents an individual mouse (n=3–6 mice/
time point). Data was pooled from 2 individual experiments. Dashed line
indicates the LOD.
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functional inactivation of the NP118–126-specific CD8
+ Tcells in
BALB/c PKO mice. Together these data demonstrate chronic
LCMV Arm infection of BALB/c PKO mice results in sub-
stantial, but not complete exhaustion of virus-specific CD8+
T cells, and are consistent with findings using LCMV Arm-
infected C57Bl/6 PKO mice (Fuller and Zajac, 2003).
Primary Tcell responses to L. monocytogenes in LCMV-infected
mice
Prolonged infection of adult WT mice with some strains of
LCMV results in generalized immunosuppression (Roost et al.,
1988; Mims and Wainwright, 1968; Oldstone et al., 1973;
Lehmann-Grube et al., 1972; Ruedi et al., 1990; Guttler et al.,
1975). To determine immunocompetency of mice with chronic
LCMV Arm infection, BALB/c PKO and BALB/c WT mice
were infected with 2×105 PFU of LCMV Arm i.p. and were
subsequently infected with ∼0.1 LD50 of attenuated actA-
deficient L. monocytogenes (Att LM) at various days after
LCMV infection. The actA-deficient strain of LM was chosen
as it is cleared similarly in WT and PKO mice (Badovinac et
al., 2000). CD8+ T cell responses to the LM antigen
listeriolysin-O (LLO)91–99 (Pamer et al., 1991) were then
determined by ICS 7 days later in LCMV-infected and LCMV-
naïve control mice (Fig. 3A). LM infection at day 119 after
LCMV infection stimulated similar expansion of LLO91–99-
specific CD8+ T cells, based on frequency (Fig. 3B) and total
numbers (Fig. 3C), in chronically infected BALB/c PKO, naïve
controls, or BALB/c WT mice that had cleared LCMV.
Consistent with previous findings, IFN-γ production by
CD8+ T cells was detectable in the absence of in vitro peptide
stimulation at day 11 p.i. in LCMV-infected PKO mice (Fig.
3B), and is likely due to persistence of viral antigen (Jordan et
al., 2004; Badovinac et al., 2003). Despite the substantial
fraction of CD8+ T cells from LCMV-infected BALB/c PKO
mice that produce IFN-γ in vitro in the absence of peptide
stimulation at day 11 post LCMV Arm infection (Fig. 3B),
LLO91–99-specific CD8
+ T cell responses were similar in all
groups of mice at this and all time points post LCMV Arm
infection (Figs. 3C, D) (p valuesN0.05). However, in both
LCMV-infected BALB/c PKO and LCMV-infected BALB/c
WT mice, the fraction of mice with detectable LLO91–99-
specific CD8+ T cell responses was reduced in mice infected
with Att LM 4 or 8 days after LCMV infection compared to
either control LCMV-naïve mice or LCMV-infected mice
challenged at days 16–288 post LCMV infection (Figs. 3C,
D). In BALB/c PKO mice challenged with Att LM at day 4 post
LCMV, 30% of mice mounted detectable LLO91–99-specific
CD8+ T cell responses, whereas 60% of BALB/c WT mice had
detectable responses. Although proximal LCMV infections
inhibited CD8+ T cell responses to heterologous Att LM
infections in both BALB/c WT and BALB/c PKO mice, these
data demonstrate that chronically infected BALB/c PKO mice
are not globally immunosuppressed and can mount vigorous
antigen-specific (Ag-specific) CD8+ T cell responses despite a
persistent LCMV infection.The magnitude of LM-specific CD8+ T cell responses are
dependent on the dose of bacteria inoculated (Badovinac et al.,
2002). Therefore, the failure to detect LLO91–99-specific CD8
+
T cell responses in some LCMV infected mice after Att LM
infection could result from enhanced bacterial clearance due to
virus-induced activation of the innate immune system (Barton
et al., 2007). To test this, BALB/c PKO and BALB/c WT mice
were infected with 2×105 PFU of LCMVArm i.p., 4 days later
infected with ∼0.1 LD50 Att LM, and bacterial clearance
determined 1 day post Att LM infection in LCMV-infected and
LCMV-naïve mice. The number of bacteria recovered from the
spleens of LCMV infected mice was reduced 33-fold (BALB/c
WT) and 104-fold (BALB/c PKO) compared to control mice
(Fig. 3E). In contrast, bacterial recovery in LCMV-infected
mice was similar to control mice when the challenge was ini-
tiated at day 12 and 24 post LCMV infection (data not shown).
These data demonstrate that bacterial clearance is enhanced in
both BALB/c PKO mice and BALB/c WT mice at early times
after LCMV infection. Furthermore, these data are consistent
with the hypothesis that failure to prime LLO91–99-specific
CD8+ T cell responses in some LCMV infected mice may be
due to enhanced clearance of the bacterial challenge resulting in
a suboptimal number of bacteria for CD8+ T cell priming.
Dendritic cell vaccination of LCMV-infected mice
To determine if LCMV Arm infection also regulates CD8+
T cell expansion independently from mechanisms mediating
enhanced bacterial clearance, BALB/c PKO mice were infected
with LCMV, subsequently vaccinated with LLO91–99-coated
DCs or infected with Att LM, and CD8+ T cell responses
Fig. 5. Generation of memory LLO91–99-specific CD8
+ T cell responses in LCMV-infected mice. (A) Experimental design. BALB/c PKO and BALB/c WT mice were
infected with 2×105 PFU of LCMVArm i.p. and 43 days later were infected with 3×106 CFU of Att LM. CD8+ Tcell responses were then analyzed at the indicated time
points after infection by LLO91–99-stimulated ICS. (B) Representative dot plots from infectedmice. Numbers represent the percentage of CD8
+ Tcells that produce IFN-
γ after incubation with (top number) or without (lower number) LLO91–99. Mean,±SEM, total number of LLO91–99 -specific CD8
+ Tcells/spleen of 4–5 mice/group in
mice that were (C) infected with LCMVor (D) were not infected with LCMV. Data was pooled from 2 individual experiments. Dashed line indicates the LOD. (E) The
mean (±SD) number of bacteria per spleenwas determined 5, 7, 15 days after LM infection in BALB/c PKO and BALB/cWTmice infectedwith LCMV43 days prior to
LM infection. Numbers indicate mice/group with detectable LM loads (n=3 mice/group). Dashed line indicates the limit of detection (LOD).
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LLO91–99-specific CD8
+ T cell responses after DC vaccination
or Att LM infection of BALB/c PKO mice infected with LCMV
4 days prior to challenge were similar to those in LCMV-naïve
BALB/c PKO mice (p valuesN0.05) (Fig. 4B). The magnitude
of CD8+ T cell expansion and the fraction of mice responding to
DCorAtt LMchallenge at day 12 or day 18 post LCMV-infection
were similar to control LCMV-naïve mice (p valuesN0.05)
(Fig. 4B). Furthermore, the magnitude of CD8+ T cell responses
to DC vaccination were indistinguishable (p valuesN0.05) from
one another at each time point tested post LCMVinfection. These
data clearly demonstrate that LCMV-chronically infected BALB/
c PKO mice can mount CD8+ T cell responses to DC vaccination
similar in magnitude to control mice.
Kinetics of LLO91–99-specific CD8
+ T cell responses in LCMV
chronically infected mice
Ag-specific CD8+ T cell responses in normal mice are
programmed early after LM infection to undergo rapid ex-
pansion followed by contraction to a stable number of memory
CD8+ T cells (Wong and Pamer, 2003; Harty and Badovinac,
2002), through a process controlled by early inflammatory sig-
nals including IFN-γ (Badovinac et al., 2002).We next sought to
determine if chronic LCMV-infection and the associated
dysregulated virus-specific immune response in BALB/c PKO
mice impacts the kinetics of LM-specific CD8+ Tcell expansion,
contraction, and memory generation. BALB/c PKO and BALB/
c WT mice were infected with LCMV, 43 days later these mice
and naïve control mice were infected with Att LM (Fig. 5A).
During CD8+ T cell expansion at day 7, the peak of expansion,
during contraction (day 15), and at the memory phase (day 216),
the frequency and total numbers of LLO91–99-specific CD8
+
T cells were similar in all groups of mice (Figs. 5B–D), dem-
onstrating that chronic LCMV infection did not negatively
impact the CD8+ T cell response to heterologous LM infection
(p valuesN0.05). Most persistently LCMV-infected PKO mice
clear LM infection with similar kinetics to WT mice that have
resolved LCMV infection (Fig. 5E). LCMV-infected WT mice
and persistently LCMV-infected PKO had similar levels of LM at
day 5 post infection (pN0.05). LM was cleared in 2 of 3 mice at
7 days p.i. and undetectable at day 15 p.i. in both LCMV-infected
PKO and WT mice. Thus, despite the dysregulation of LCMV-
specific CD8+ T cell responses in LCMV chronically infected
BALB/c PKOmice, the CD8+ T cell response program is normal
following heterologous LM infection. Furthermore, LM-specificFig. 6. Phenotype and expansion of memory LLO91–99 -specific CD8
+ T cells genera
with 2×105 PFU of LCMVArm i.p., 43 days later LCMV-infected mice and naïve
vaccination all groups were infected with 3×104 CFU of Vir LM i.v. LLO91–99-stim
expression by ICS in combination with staining for IL-2, CD27, the activation-assoc
d43+67 p.i. Numbers represent the percentage of CD8+ T cells that produce IFN-γ i
production by IFN-γ+ CD8+ T cells. Numbers represent the mean percentage±SD
Representative histograms of IFN-γ+ CD8+ T cells analyzed for CD27, CD43, CD6
histograms). Numbers represent the mean percentage±SD of IFN-γ+ CD8+ T cel
determined at day 6 post secondary challenge by ICS. Mean,±SD, total number of LL
day 0 (open bars) and day 6 post Vir LM challenge. Data was pooled from 2 individ
mean number of bacteria per spleen was determined 2 days after Vir LM infection. E
spleen. Data was pooled from 2 individual experiments (n=3–6 mice/group). DashCD8+ T cells can mediate bacterial clearance, even in LCMV-
persistently infected PKO mice.
As primary antigen-specific CD8+ T cell populations prog-
ress into memory, they undergo gradual phenotypic changes,
including acquiring the ability to make IL-2 upon stimulation,
enhanced expression of CD27, CD127, and CD62L, and loss of
the activation-associated CD43 glycoform (Wherry and Ahmed,
2004). To characterize the impact of chronic infection on
differentiation of memory CD8+ T cells, BALB/c PKO and
control BALB/c WT mice were infected with LCMV and Att
LM, as above. Sixty-seven days later, the LLO91–99-specific
CD8+ Tcells were identified by IFN-γ production, and analyzed
for expression of IL-2, CD27, CD127, CD43, and CD62L
(Fig. 6A). IL-2 production by LLO91–99-specific CD8
+ Tcells in
chronically infected BALB/c PKO mice was similar to LCMV-
naïve BALB/c PKO mice as well as control LCMV-infected
and LCMV-naive BALB/c WT mice (Fig. 6B). The fraction
of memory antigen-specific CD8+ T cells scoring CD27+,
CD43high, CD62Lhigh, and CD127+ (Fig. 6C) and total
number of LM-specific memory CD8+ T cells (Figs. 6D, E)
were similar amongst LCMV-infected and LCMV-naïve
groups of BALB/c WT and BALB/c PKO mice. In conclusion,
these data demonstrate that chronic LCMV infection of BALB/c
PKO does not impact the phenotype or number of memory
CD8+ T cells following heterologous Att LM infection.
Consistent with their phenotype, LM-specific memory CD8+
T cells generated in chronically infected BALB/c PKO and
control mice undergo equivalent expansion after secondary
virulent L. monocytogenes (Vir LM) challenge (Figs. 6D, E).
Both vaccinated LCMV-infected PKO and WT mice survived
secondary challenge with a lethal dose of Vir LM (data not
shown) and control infection in contrast to unvaccinated control
mice (Fig. 6F) (pb0.05). LM load was similar in all vaccinated
groups of mice (pN0.05), demonstrating persistent LCMV
infection does not impact the ability of memory LM-specific
CD8+ T cells to mediate bacterial clearance.
Function and fate of pre-existing memory CD8+ T in LCMV
chronically infected mice
Acute LCMVArm infection of WT mice induces the attrition
of pre-existingmemory CD8+ Tcells (Bahl et al., 2006;McNally
et al., 2001). However, the impact of chronic LCMVinfection on
pre-existing non-virus-specific memory CD8+ T cell phenotype
and function remains unclear. Therefore, BALB/c PKO and
control BALB/c WT mice were vaccinated with Att LM toted in LCMV-infected mice. BALB/c PKO and BALB/c WT mice were infected
control mice were vaccinated with 3×106 CFU of Att LM. At day 69 after LM
ulated CD8+ T cell were then analyzed at d67 post Att LM infection for IFN-γ
iated glycoform of CD43, CD62L, and CD127. (A) Representative dot plots at
n the absence or presence of peptides. (B) Representative contour plots of IL-2
of IFN-γ+ CD8+ T cells staining positive for IL-2 or (isotype control). (C)
2L, and CD127 expression (solid histograms) or isotype control staining (open
ls staining positive for each phenotypic marker. CD8+ T cell responses were
O91–99 -specific (D) and (E) p60217–225 -specific CD8
+ T cells/spleen in mice at
ual experiments (n=3–6 mice/group). Dashed line indicates the LOD. (F) The
ach symbol represents an individual mouse. Solid lines indicate the mean CFU/g
ed line indicates the limit of detection (LOD).
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later, and LM-specific memory CD8+ T cells analyzed for
memory markers and function at day 73 post LCMV infection
(Fig. 7A). LLO91–99-specific memory CD8
+ Tcells from LCMV
infected BALB/c PKO mice produced IL-2 (Fig. 7B) and
expressed CD27, CD43, CD62L, and CD127 similar in
proportions and intensities as those seen in the control groups
of mice (Fig. 7C). Although the phenotype of pre-existing
memory was not affected by chronic or acute LCMV-infection,
the numbers of LLO91–99-specific CD8
+ T cells/spleen in
LCMV-infected BALB/c PKO and BALB/c WT mice were
reduced ∼3.0- and 3.4-fold, respectively (Fig. 7D). Similarly,
BALB/c PKO and BALB/cWTmice had reduced p60 217–225-
specific memory CD8+ T cells/spleen, ∼3.8- and ∼1.5-fold
respectively, at day 73 post LCMV infection (Fig. 7E). Thus,
chronic LCMV infection can result in a perforin-independent
attrition of memory Ag-specific CD8+ T cells. Despite this
attrition, secondary expansion of LM-specific CD8+ T cells was
robust in LCMV infected BALB/c PKO mice and resulted in
generation of similar numbers of secondary memory cells in all
groups of mice (Figs. 7D, E). Both vaccinated LCMV-infected
PKO and WT mice survived secondary challenge with a lethal
dose of Vir LM (data not shown) and reduced infection in
contrast to unvaccinated control mice (Fig. 7F) (pb0.05). LM
load was similar in vaccinated PKO and WT mice (pN0.05),
demonstrating that neither acute nor persistent LCMV infection
impacts the ability of memory LM-specific CD8+ T cells to
mediate bacterial clearance.
Discussion
Many gene mutations have been found to cause primary
immunodeficiencies, including perforin gene mutations, which
result in impaired NK and CD8+ Tcell function and an increased
susceptibility to viral infections. In addition, PKO mice serve as
an excellent model of the human disease, FHL (Jordan et al.,
2004; Badovinac et al., 2003). Furthermore, viral infections, like
LCMV infections, can result in disruption of CD8+ T cell func-
tion and immunosuppression. However, the impact of primary
immunodeficiency combined with persistent viral infections
in responses to heterologous CD8+ T cell responses is poorly
characterized. In this study, we have investigated the impact of
chronic LCMV infection on general immunocompetency and
virus-specific CD8+ T cell responses in perforin-deficient hosts.
Taken together, our findings reveal three main points regarding
CD8+ T cell responses in LCMV Arm chronically infected
PKO mice. First, although chronic viral infection of PKO miceFig. 7. Phenotype and function of pre-existing LLO91–99 -specific memory CD8
+ Tcell
mice were vaccinatedwith 3×106 CFU of Att LM and infected with 2×105 PFU of LCM
day 73 post LCMVArm infection for IFN-γ expression by ICS in combination with st
CD127. (B) Representative contour plots of IFN-γ+ CD8+ T cells analyzed for IL-2 pr
CD8+ T cells or (isotype control). (C) Representative histograms of IFN-γ+ CD8+ T cel
control (open histograms). Numbers represent the mean percentage±SD of IFN-γ+ CD8
determined at day 6 and 35 post secondary challenge by ICS. Mean,±SD, total number
1 day prior to Vir LM challenge (solid bars), at day 6 p.i. (open bars), and at day 35 p.i. (
time group. Dashed line indicates the limit of detection (LOD). (F) The mean number
represents an individual mouse. Solid lines indicate the mean CFU/g spleen (n=3 micnegatively impacted virus-specific CD8+ T cell number and
function, these mice mounted normal CD8+ T cell responses to
primary infections with heterologous pathogens. Second, fol-
lowing vaccination, memory CD8+ T cells specific for non-
LCMV antigens were generated, maintained, and functioned
normally in LCMVArm chronically infected PKOmice. Finally,
pre-existing memory CD8+ T cells undergo attrition following
viral infection in chronically infected BALB/c PKO similar to
infected WT mice, but maintain their memory phenotype and
respond normally to secondary challenge. Thus, our data suggest
that global immunosuppression is not always concurrent with
persistent or prolonged LCMV infection of adult mice. Fur-
thermore, persistent LCMV infection of immunodeficient hosts
does not negatively impact heterologous immune responses.
Persistent viral infections often result in immunosuppression
of CD8+ T cell responses and can be associated with functional
disruptions (such as exhaustion) and deletion of CD8+ T cells
(Liu et al., 2002; Kostense et al., 2001; Schlaak et al., 1999;
Wedemeyer et al., 2002; Greten et al., 1998). In models of
LCMV infection using fast growing strains, such as LCMVCl13
and LCMV Docile, infection of adult mice results in prolonged
viral loads, exhaustion and deletion of virus-specific CD8+
T cells (Wherry et al., 2003), and generalized immunosuppres-
sion. In agreement with these models and our previous results
(Badovinac et al., 2002; Fuller and Zajac, 2003), data shown
here demonstrates that LCMVArm infection is not cleared from
BALB/c PKO mice, that chronic infection is associated with a
substantial, yet incomplete exhaustion of NP118–126-specific
CD8+ T cells and furthermore, the exhaustion of GP283–291-
specific CD8+ Tcells. In contrast to LCMV-specific CD8+ Tcell
responses, Listeria-specific CD8+ T cell responses were not
suppressed by persistent LCMV infection. Resistance to LM
infection of normal WT mice, in part, depends on functional
CD8+ T cells (Harty and Bevan, 1992; Badovinac et al., 2002);
however, the disruption of CD8+ T cells' responses after LCMV
infection of PKO mice appears to be limited to virus-specific
CD8+ T cells and not LM-specific cells.
These data suggest that neither the disruption of virus-
specific CD8+ Tcells alone, nor persistent LCMV-Arm infection
in combination with perforin-deficiency, are sufficient for global
immunosuppression. One explanation is that perforin is required
for both clearance of LCMV and long lasting LCMV-induced
immunosuppression. LCMV-induced immunosuppression has
been linked to the infection and subsequent destruction and
functional disruption of LCMV-infected DCs (Borrow et al.,
1995; Sevilla et al., 2004) and requires CD8+ T cells. (Borrow
et al., 1995). And more generally, APC survival is limited afterin LCMV-infected mice. (A) Experimental design. BALB/c PKO and BALB/cWT
VArm i.p. 42 days later. LLO91–99 -specific memory CD8
+ Tcell were analyzed at
aining for IL-2, CD27, the activation-associated glycoform of CD43, CD62L, and
oduction. Numbers represent the mean percentage±SD of IL-2 producing IFN-γ+
ls analyzed for expression of each phenotypic marker (solid histograms) or isotype
+ Tcells staining positive for each phenotypic marker. CD8+ Tcell responses were
of (D) LLO91–99 -specific and (E) p60217–225 -specific CD8
+ T cells/spleen in mice
diagonally striped bars). Data is representative of duplicate experiments. n=3 mice/
of bacteria per spleen was determined 2 days after Vir LM infection. Each symbol
e/group). Dashed line indicates the limit of detection (LOD).
319T.D. Humphreys et al. / Virology 370 (2008) 310–322the initial activation of Tcells (Hermans et al., 2000), however, a
role for perforin in the destruction of APCs in vivo remains
controversial (Ludewig et al., 2001; Yang et al., 2006). It is
possible that in the absences of perforin, CD8+ T cells in per-
sistently infected PKO mice are unable to cause sufficientelimination of DC to mediate lasting immunosuppression. Fur-
thermore, LCMV Arm targets and disrupts DCs to a limited
extent, compared to fast growing LCMV strains (Sevilla et al.,
2000; Borrow et al., 1995). This could account for the failure of
LCMVArm tomediate generalized immunosuppression, even in
320 T.D. Humphreys et al. / Virology 370 (2008) 310–322chronically infected PKO mice. We show here that persistent
LCMV Arm does not significantly suppress CD8+ T cell
responses to LM up to 228 days post LCMV infection
(Fig. 3C). It is possible that persistent LCMV Arm infection
may be globally immunosuppressive only at very late time point
after LCMV infection. However, this seems unlikely given that
infection of mice with fast growing LCMV isolates are most
immunosuppressive proximal to LCMV infection and that
immunosuppression wanes with time (Ruedi et al., 1990;
Mims and Wainwright, 1968). Immunosuppression in our
model more closely resembles carrier state models of LCMV
infection, where wildtype (WT) mice are infected prior to, or
shortly after birth. Chronic LCMVArm infection of PKO mice,
like LCMV carrier mice, both manifest disruptions in LCMV-
specific T cells responses, although most likely by different
mechanisms (Wherry et al., 2003; Jamieson and Ahmed,
1988), while remaining competent to respond to heterologous
infections (Oldstone et al., 1973; Oldstone, 2002). This again, is
likely due to preservation of DCs and DC function in these
models, in contrast to LCMVCl13 infection of adult mice.
Previous studies of immunocompetency in LCMV-infected
mice have focused on immune responses to primary heterologous
challenges, while the impact of LCMV infection, in the either
presence or absence of an underlying primary immunodeficien-
cies on CD8+ T cell memory, has remained unclear. We show
here that LM-specific CD8+ T cell memory is generated,
maintained, and functions normally following secondary infec-
tion in chronically infected immunodeficient BALB/c PKO
mice. However, as has been shown previously, LCMV Arm
infection of WT mice can result in a rapid ∼2-fold reduction in
pre-existing memory CD8+ T cells in the spleen (McNally et al.,
2001). We show here that the number of memory LM-specific
CD8+ T cells is reduced 1.5- to 3.8-fold in the spleens 72 days
after LCMV Arm infection of BALB/c PKO mice, and to a
similar degree in WT mice. Thus, the attrition in LM-specific
memory CD8+ T cell number after LCMV Arm infection is
perforin-independent and also occurs in chronically infected
mice. The remaining memory LM-specific CD8+ T cells in
LCMV-infectedmice are phenotypically and functionally similar
to those in LCMV-naïve mice. In both LCMV-naïve and
chronically infected groups of mice, memory CD8+ T cells
protect from secondaryVir LM challenge and expand vigorously.
These data suggest that despite a reduction in Ag-specific cell
number, chronically infected BALB/c PKO mice mount normal
CD8+ T cell responses upon secondary challenge. However, it is
possible that the relatively high level of memory Ag-specific
CD8+ T cells remaining are adequately stimulated by LM
infections, whereas secondary response to other heterologous
pathogens in chronically infected mice may be more sensitive to
a small reduction in the number of memory cells. Although the
factors regulating infection-induced lymphopenia have yet to be
decisively determined, the magnitude of the ensuing T cell
response and type I interferon production following infection are
likely to be key factors (Bahl et al., 2006; McNally et al., 2001).
Taken together, these data demonstrate that persistent LCMV
Arm infection disrupts specifically virus-specific CD8+ T cells
without impacting primary or secondary Listeria-specificresponses. The absence of perforin did not impact the LCMV-
mediated disruption of CD8+ Tcells or CD8+ Tcell responses to
heterologous infection in LCMV-chronically infected hosts.
More generally, these data demonstrate the efficacy of Listeria-
based vaccines vectors, even in chronically infected hosts with
underlying primary immunodeficiency.
Materials and methods
Mice
8- to 10-week-old female WT BALB/c mice were purchased
from the National Cancer Institute (Frederick, MD). BALB/c
PKOmice (White et al., 1999) were maintained by brother–sister
mating. All mice were housed under specific pathogen-free
conditions at the University of Iowa (Iowa City, IA) animal care
unit and experiments followed approved institutional animal care
and use protocols. Mice were transferred to the appropriate
biosafety level prior to infection with LCMV and/or LM.
Abs, peptides, and tetramer
The following mAbs were used: IFN-γ-APC (clone
XMG1.2), IL-2-PE (clone JES6-5H4), CD27-PE (clone
LG.7F9), CD127-PE (clone A7R34), IgG Isotype control-PE
from eBiosciences (San Diego, CA) and CD8α-PerCP and
CD8α-FITC (clone 53–6.7), CD43-PE (clone 1B11), CD62L-
PE (clone MEL-14), Thy1.2-FITC (clone 53–2.1), IgG Isotype
control-PE from BD PharMingen (San Jose, CA). Synthetic
peptides representing defined H-2Kd-restricted listeriolysin O
(LLO) 91–99 (Pamer et al., 1991), p60 217–225 (Harty and
Pamer, 1995), LCMVglycoprotein (GP) 283–291 (van derMost
et al., 1996) and H-2Ld-restricted LCMV nucleoprotein (NP)
118–126 (van der Most et al., 1996) were obtained from
Biosynthesis (Lewisville, TX). MHC class I tetramers specific
for NP118–126 were prepared as previously described (Altman et
al., 1996) or obtained from the National Institute of Allergy and
Infectious Diseases tetramer core (Atlanta, GA).
LCMV infections and titers
The Armstrong strain of LCMV was used at 2×105 PFU/
mouse injected intraperitoneally (Badovinac et al., 2003). Viral
titers in homogenates of spleen, lung, kidney, and brain were
determined by plaque assay on VERO cells (ATCC; Manassas,
VA) (Shen et al., 1998).
LM infection of mice and colony-forming unit (CFU) detection
Vaccinations and primary infections of mice used∼0.1 LD50
(3×106 CFU) attenuated (actA-deficient) LM strain DP-L1942
(Brundage et al., 1993). Secondary infection of memory mice
used ∼2–3 LD50 (3–6×104 CFU) virulent LM strain 10403s,
as indicated. Bacteria were grown, injected, and quantified as
described (Harty and Bevan, 1995). CFU of LM per gram
spleen or liver were determined at the indicated times post
infections (Harty and Bevan, 1995).
321T.D. Humphreys et al. / Virology 370 (2008) 310–322Quantification and phenotypic analysis of Ag-specific CD8+ Tcells
Intracellular cytokine staining (ICS) or MHC class I te-
tramer staining was performed as previously described
(Badovinac et al., 2000). For ICS, splenocytes were cocultured
with 2 μL/mL GolgiPlug (BD PharMingen) in the presence or
absence of specific peptide for 5.5 h. Cells were then washed,
surface stained, and treated with Cytofix/Cytoperm (BD
PharMingen) before cytokine staining. The percentage of
IFN-γ+ CD8+ T cells in unstimulated samples from each mouse
was subtracted from the peptide-stimulated value to determine
the percentage of Ag-specific CD8+ T cells. Next, the total
number of epitope-specific CD8+ T cells per spleen was
calculated from the percentage of IFN-γ+ CD8+ T cells, the
percentage of CD8+ T cells in each sample, and the total
number of cells per spleen. For phenotypic analysis, cells were
stained, as above, and the percentage of IFN-γ+ CD8+ T cells
scoring positive for each marker calculated. Cells stained for
CD62L expression were pretreated with 100 mM TAPI-2
(Peptides International; Louisville, KY) for 45 min prior to
peptide stimulation to prevent CD62L cleavage (Jabbari and
Harty, 2006).
Peptide-coated dendritic cells
CD11c+ bone marrow derived dendritic cells (DCs) were
generated as previously described (Hamilton and Harty, 2002).
Bone marrow cells were depleted of RBC, subjected to com-
plement depletion after incubation with mAbs 3.168 (CD8-
specific), RL172 (CD4-specific), and RA3-3A1/6.1 (B220/
CD45R-specific) and cultured for 5 days in medium
supplemented with 1000 U/ml rGM-CSF (BD PharMingen)
and 25 U/ml rIL-4 (PeproTech, Rocky Hill, NJ). Loosely
adherent cells were harvested and depleted of neutrophils by
complement depletion with the Ly-6G-specific Ab RB6.8C5.
LPS (500 ng/ml; Sigma-Aldrich, St. Louis, MO) was then
added to cultures of the remaining cells for 1 day to induce
maturation. Next, cultures were incubated with 1 μM peptide
for 3 h, washed 3 times, and injected i.v. at 2×105 DC per
mouse.
Statistical analysis
When comparing three or more groups of data, an ANOVA
with Tukey's post-test was used. Student's t-test was used when
comparing two groups of data. p values≤0.05 were considered
significant.
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